SHINE Announces Two Strategic Appointments to Advance Fusion Technology and Market Expansion

Healthcare technology leader Dr. Gregory Sorensen joins Board of Directors; Defense expert Col. (Ret.) Gregory Van Dyk joins as Strategic Advisor

JANESVILLE, Wis., May 21, 2025 /PRNewswire/ — SHINE Technologies, LLC, a next-generation fusion technology company with commercialized platforms in industrial testing and medical isotopes, today announced the appointments of Dr. Gregory Sorensen, co-founder of DeepHealth and Chief Science Officer of RadNet, and Col. (Ret.) Gregory K. Van Dyk, U.S. Air Force, as strategic advisor to its Board of Directors.

These appointments bring deep expertise in healthcare technology and national security to SHINE as the company expands the reach of its fusion applications across commercial and defense markets.

“Fusion technology provides real-world solutions to big infrastructure problems in highly specialized markets,” said Greg Piefer, founder and CEO of SHINE. “These appointments expand our ability to understand and access these markets quickly. Dr. Sorensen is a strong addition to our already distinguished board, having rare depth in the healthcare space that spans founding, growing, and selling startups through executive operations at multinational conglomerates. Col. Van Dyk brings a career of leadership and widespread connectivity in the radiation effects testing arena, with a specific focus on the effects of DT fusion neutrons.”

Dr. Sorensen: Guiding Commercial Strategy and Innovation

Dr. Sorensen brings decades of experience at the intersection of healthcare, imaging, and technology. As co-founder of DeepHealth (now RadNet’s AI division) and former President and CEO of Siemens Healthcare North America, he has led the development and commercialization of transformative medical technologies.

He will advise SHINE on strategic growth initiatives, partnerships, and the expansion of its fusion-enabled medical isotope business.

“SHINE represents the promise of fusion – not as a science experiment, but as a real-world solution,” said Dr. Sorensen. “I’m excited and honored to help guide the company’s growth into new healthcare and commercial markets.”

Col. (Ret.) Van Dyk: Advancing National Security through Fusion

Col. (Ret.) Van Dyk, Ph.D. joins SHINE following a distinguished 22-year career in the U.S. Air Force, where he specialized in nuclear engineering, fusion technology, and strategic deterrence. He previously led the Department of Defense’s Fusion for National Security initiative and managed a $207 million annual R&D portfolio at the National Nuclear Security Administration along with leading two multi-billion-dollar programs in the Department of Defense.

His appointment comes at a critical time as SHINE expands FLARE (Fusion Linear Accelerator for Radiation Effects), a high-energy neutron testing service that enables defense contractors to evaluate the resilience of microelectronics and mission-critical systems in extreme radiation environments.

“SHINE’s fusion platform is practical, innovative, and timely,” said Van Dyk. “FLARE offers a new capability for understanding how our most important defense technologies perform under the toughest conditions.”

About SHINE 

Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, cost-efficiency and environmental responsibility. 

SHINE has successfully commercialized fusion across multiple applications, including neutron testing markets such as neutron radiography, radiation-effects testing and fusion material research. It has commercialized and is scaling its proprietary medical isotope production, processes, supplying high-quality radioisotopes essential for procedures including diagnosing heart disease and cancer as well as cancer therapy.  

Beyond these applications, SHINE is pioneering nuclear waste recycling to make nuclear energy more sustainable. Its long-term purpose is to change the way humans make energy by commercializing fusion energy. Unlike other fusion companies, SHINE takes a commercially driven path mirroring successful deep-tech industries. Through this visionary approach, SHINE is advancing technology, healthcare, and sustainable energy, making a lasting impact across multiple sectors. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/shine-announces-two-strategic-appointments-to-advance-fusion-technology-and-market-expansion-302462344.html

SOURCE SHINE Technologies, LLC